Serum bilirubin level is negatively correlated with disease progression of peripheral arterial disease: An observational cohort study

Angiology

Volumn 63, Issue 4, 2012, Pages 248-253

  Wang, Hai Yang ^a   Han, Peng ^a   Zhang, Wei Hui ^a   Liu, Bing ^a   Li, Ha Li ^a   Wang, Hai Jun ^a   Huang, Ren Ping ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

atherosclerosis; bilirubin; peripheral arterial disease; risk factor

Indexed keywords

BILIRUBIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BILIRUBIN BLOOD LEVEL; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; SEX DIFFERENCE;

EID: 84859738992     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319711425175     Document Type: Article

References (29)

1. Fujiwara T, Saitoh S, Takagi S, et al. Prevalence of asymptomatic arteriosclerosis obliterans and its relationship with risk factors in inhabitants of rural communities in Japan: Tanno-Sobetsu study. Atherosclerosis. 2004;177(1):83-88. (Pubitemid 39361142)
2. Mutirangura P, Ruangsetakit C, Wongwanit C, Sermsathanasawadi N, Chinsakchai K. Atherosclerosis obliterans of the lower extremities in Thai patients. J Med Assoc Thai. 2006;89(10):1612-1620. (Pubitemid 44753099)
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Rutherford RB; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Int Angiol. 2007;26(2):81-157. Review.
4. Schwertner HA, Jackson WG, Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994;40(1):18-23. (Pubitemid 24050206)
5. Breimer LH, Spyropolous KA, Winder AF, Mikhailidis DP, Hamilton G. Is bilirubin protective against coronary artery disease? Clin Chem. 1994;40(10):1987-1988. (Pubitemid 24332717)
6. Krijgsman B, Papadakis JA, Ganotakis ES, Mikhailidis DP, Hamilton G. The effect of peripheral vascular disease on the serum levels of natural anti-oxidants: bilirubin and albumin. Int Angiol. 2002;21(1):44-52. (Pubitemid 34413653)
7. Novotný L, Vítek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 2003;228(5):568-571. (Pubitemid 37203679)
8. Vítek L, Novotný L, Sperl M, Holaj R, Spácil J. The inverse association of elevated serum bilirubin levels with subclinical carotid atherosclerosis. Cerebrovasc Dis. 2006;21(5-6):408-414. (Pubitemid 44617309)
9. Perlstein TS, Pande RL, Beckman JA, Creager MA. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol. 2008;28(1):166-172.
10. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis. 2001;154(3):747-754. (Pubitemid 32232174)
11. Rantner B, Kollerits B, Anderwald-Stadler M, et al. Association between the UGT1A1 TA-repeat polymorphism and bilirubin concentration in patients with intermittent claudication: results from the CAVASIC study. Clin Chem. 2008;54(5):851-857. (Pubitemid 351671602)
12. Schwertner HA, Vítek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198(1):1-11.
13. Troughton JA, Woodside JV, Young IS, et al. PRIME Study Group. Bilirubin and coronary heart disease risk in the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Eur J Cardiovasc Prev Rehabil. 2007;14(1):79-84.
14. Ohnaka K, Kono S, Inoguchi T, et al. Inverse associations of serum bilirubin with high sensitivity C-reactive protein, glycated hemoglobin, and prevalence of type 2 diabetes in middle-aged and elderly Japanese men and women. Diabetes Res Clin Pract. 2010;88(1):103-110.
15. Wu TW, Fung KP, Wu J, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol. 1996;51(6):859-862. (Pubitemid 26096296)
16. Yang JJ, Cheng YT, Zhang JH. The relationship between bilirubin and oxygen free radicals and cardiovascular diseases. Chin J Arteriosclerosis. 2006;14:53-56.
17. Gullu H, Erdogan D, Tok D, et al. High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions. Arterioscler Thromb Vasc Biol. 2005;25(11):2289-2294. (Pubitemid 41552644)
18. Lingenhel A, Kollerits B, Schwaiger JP, et al. Serum bilirubin levels, UGT1A1 polymorphisms and risk for coronary artery disease. Exp Gerontol. 2008;43(12):1102-1107.
19. Suematsu M, Ishimura Y. The heme oxygenase-carbon monoxide system: a regulator of hepatobiliary function. Hepatology. 2000;31(1):3-6. (Pubitemid 30033680)
20. Breimer LH, Mikhailidis DP. Could carbon monoxide and bilirubin be friends as well as foes of the body? Scand J Clin Lab Invest. 2010;70(1):1-5.
21. Ollinger R, Bilban M, Erat A, et al. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation. 2005;112(7):1030-1039. (Pubitemid 41170272)
22. Vicente AM, Guillin MI, Alcaraz MJ. Participation of heme oxygenase-1 in a model of acute inflammation. Exp Biol Med (Maywood). 2003;228(5):514-516. (Pubitemid 37203669)
23. Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol. 2010;80(12):1895-1803.
24. Ekblom K, Marklund SL, Johansson L, et al. Bilirubin and UGT1A1*28 are not associated with lower risk for ischemic stroke in a prospective nested case-referent setting. Cerebrovasc Dis. 2010;30(6):590-596.
25. Ekblom K, Marklund SL, Jansson JH, et al. Plasma bilirubin and UGT1A1*28 are not protective factors against first-time myocardial infarction in a prospective, nested case-referent setting. Circ Cardiovasc Genet. 2010;3(4):340-347.
26. Poss KD, Tonegawa S. Reduced stress defense in heme oxygenase 1-deficient cells. Proc Natl Acad Sci U S A. 1997;94(20):10925-10930. (Pubitemid 27430837)
27. Nakayama M, Takahashi K, Komaru T, et al. Increased expression of heme oxygenase l and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arteroscler Thromb Vasc Biol. 2001;21(8):1373-1377. (Pubitemid 34219847)
28. Amit Y, Boneh A. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta. 1993;223(1-2):103-111. (Pubitemid 24050914)
29. Zou T, Yang W, Hou Z, Yang J. Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin (Shanghai). 2010;42(12):908-915.